journal article·2024-11Open access

A New Strategy to Inhibit Scar Formation by Accelerating Normal Healing Using Silicate Bioactive Materials

Zhaowenbin Zhang, Chen Fan, Qing Xu, Feng Guo, Wenbo Li, Zhen Zeng, Yuze Xu, Jing Yu, Hongping Ge, Chen Yang, Jiang Chang

Advanced Science· Volume 11· Issue 43

Abstract

Abstract Inspired by the scar‐free wound healing in infants, an anti‐scar strategy is proposed by accelerating wound healing using silicate bioactive materials. Bioglass/alginate composite hydrogels are applied, which significantly inhibit scar formation in rabbit ear scar models. The underlining mechanisms include stimulation of Integrin Subunit Alpha 2 expression in dermal fibroblasts to accelerate wound healing, and induction of apoptosis of hypertrophic scar fibroblasts by directly stimulating the N‐Acylsphingosine Amidohydrolase 2 expression in hypertrophic scar fibroblasts, and indirectly upregulating the secretion of Cathepsin K in dermal fibroblasts. Considering specific functions of the bioactive silicate materials, two scar treatment regimes are tested. For severe scars, a regenerative intervention is applied by surgical removal of the scar followed by the treatment with bioactive hydrogels to reduce the formation of scars by activating dermal fibroblasts. For mild scars, the bioactive dressing is applied on the formed scar and reduces scar by inducing scar fibroblasts apoptosis.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Wound Healing and Treatments · Dermatologic Treatments and Research · Surgical Sutures and Adhesives

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Joint Centre of Translational Medicine The First Affiliated Hospital of Wenzhou Medical University Wenzhou 325000 P. R. China

Zhejiang Engineering Research Center for Tissue Repair Materials Wenzhou Institute University of Chinese Academy of Sciences Wenzhou 325000 P. R. China

State Key Laboratory of High‐Performance Ceramics and Superfine Microstructure Shanghai Institute of Ceramics Chinese Academy of Sciences Shanghai 200050 P. R. China

Department of Plastic Surgery Shanghai Jiaotong University Affiliated Sixth People's Hospital Shanghai 200050 P. R. China

Funding

China Postdoctoral Science Foundation · National Natural Science Foundation of China · School of Medicine, Shanghai Jiao Tong University · University of Chinese Academy of Sciences

References (63)

Show source-provided references
1. 10.1016/j.burns.2014.02.01110.1016/j.burns.2014.02.011 ↗
2. 10.1016/j.mtbio.2024.10107510.1016/j.mtbio.2024.101075 ↗
3. 10.1016/j.apmt.2021.10106510.1016/j.apmt.2021.101065 ↗
4. 10.3390/ijms2102061710.3390/ijms21020617 ↗
5. 10.1038/s41536-020-0095-210.1038/s41536-020-0095-2 ↗
6. 10.1111/iwj.1328610.1111/iwj.13286 ↗
7. 10.1111/wrr.1206210.1111/wrr.12062 ↗
8. 10.1016/j.ebiom.2020.10271510.1016/j.ebiom.2020.102715 ↗
9. 10.1111/j.1524-475X.2011.00708.x10.1111/j.1524-475X.2011.00708.x ↗
10. Namgoong S. · Br. J. Plast. Surg. · 2022 · 75 · 2775
11. 10.1016/j.jaad.2011.06.01610.1016/j.jaad.2011.06.016 ↗
12. 10.1111/j.1365-4632.2010.04678.x10.1111/j.1365-4632.2010.04678.x ↗
13. 10.1089/ten.teb.2018.035010.1089/ten.teb.2018.0350 ↗
14. 10.1016/S1937-6448(10)82004-010.1016/S1937-6448(10)82004-0 ↗
15. 10.1097/MOP.0b013e328353579010.1097/MOP.0b013e3283535790 ↗
16. 10.1016/j.arr.2017.02.00510.1016/j.arr.2017.02.005 ↗
17. 10.1111/j.1524-475X.2010.00585.x10.1111/j.1524-475X.2010.00585.x ↗
18. 10.1016/j.actbio.2012.10.01910.1016/j.actbio.2012.10.019 ↗
19. 10.1016/j.actbio.2017.03.05610.1016/j.actbio.2017.03.056 ↗
20. 10.1021/acsami.5b0985310.1021/acsami.5b09853 ↗
21. 10.1039/C5TB01758K10.1039/C5TB01758K ↗
22. 10.1093/rb/rbae02810.1093/rb/rbae028 ↗
23. 10.1039/D3TB01287E10.1039/D3TB01287E ↗
24. 10.1016/j.apmt.2021.10106510.1016/j.apmt.2021.101065 ↗
25. 10.1016/j.bioactmat.2021.02.01310.1016/j.bioactmat.2021.02.013 ↗
26. 10.1016/j.actbio.2022.12.00610.1016/j.actbio.2022.12.006 ↗
27. 10.1002/adfm.20211146510.1002/adfm.202111465 ↗
28. 10.1002/adfm.20220228510.1002/adfm.202202285 ↗
29. 10.1002/adma.20230084010.1002/adma.202300840 ↗
30. 10.1016/j.mattod.2018.07.01610.1016/j.mattod.2018.07.016 ↗
31. 10.1016/j.biomaterials.2020.12041410.1016/j.biomaterials.2020.120414 ↗
32. 10.1021/acsami.9b2276910.1021/acsami.9b22769 ↗
33. 10.1002/adhm.20180014410.1002/adhm.201800144 ↗
34. 10.1039/C7TB01211J10.1039/C7TB01211J ↗
35. Wang H. · Cell. Mol. Biol. · 2016 · 62 · 33
36. 10.3389/fcell.2021.71360510.3389/fcell.2021.713605 ↗
37. Li K. Y. · Latin Am. J. Pharm. · 2017 · 36 · 437
38. 10.1002/iid3.9010.1002/iid3.90 ↗
39. 10.3748/wjg.v22.i20.488110.3748/wjg.v22.i20.4881 ↗
40. 10.1016/j.jstrokecerebrovasdis.2020.10521010.1016/j.jstrokecerebrovasdis.2020.105210 ↗
41. 10.1590/fst.2562210.1590/fst.25622 ↗
42. 10.1096/fj.201600611R10.1096/fj.201600611R ↗
43. 10.3390/cells812157310.3390/cells8121573 ↗
44. 10.3390/cells1112187310.3390/cells11121873 ↗
45. 10.1183/13993003.01201-201510.1183/13993003.01201-2015 ↗
46. Tan S. · Front. Immunol. · 2019 · 10
47. 10.1038/s41586-023-06198-y10.1038/s41586-023-06198-y ↗
48. 10.1038/s41569-018-0002-310.1038/s41569-018-0002-3 ↗
49. 10.1111/wrr.1295210.1111/wrr.12952 ↗
50. 10.1159/00005183010.1159/000051830 ↗
51. 10.1016/j.drudis.2008.08.00910.1016/j.drudis.2008.08.009 ↗
52. 10.1111/j.1524-4725.2001.99315.x10.1111/j.1524-4725.2001.99315.x ↗
53. 10.1002/jcp.2930210.1002/jcp.29302 ↗
54. 10.1016/j.actbio.2013.02.01410.1016/j.actbio.2013.02.014 ↗
55. 10.1016/j.biomaterials.2016.01.03310.1016/j.biomaterials.2016.01.033 ↗
56. 10.1016/j.actbio.2018.03.05110.1016/j.actbio.2018.03.051 ↗
57. 10.1038/nmeth.331710.1038/nmeth.3317 ↗
58. 10.1021/acsami.7b0480110.1021/acsami.7b04801 ↗
59. 10.1039/C7TB00571G10.1039/C7TB00571G ↗
60. 10.1097/PRS.000000000000527510.1097/PRS.0000000000005275 ↗
61. 10.2310/7750.2008.0704110.2310/7750.2008.07041 ↗
62. 10.1111/exd.1241910.1111/exd.12419 ↗
63. 10.1097/00006534-199709000-0002110.1097/00006534-199709000-00021 ↗